Comparison between mono-tacrolimus and mono-glucocorticoid in the treatment of myasthenia gravis.

Annals of clinical and translational neurology(2023)

引用 0|浏览7
暂无评分
摘要
Mono-tacrolimus performs superior tolerability with non-inferior efficacy compared to mono-glucocorticoids in mild to moderate myasthenia gravis patients who refuse or have a contraindication to glucocorticoids.
更多
查看译文
关键词
myasthenia gravis
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要